Novartis Chooses North Carolina for New PlanT:

Swiss pharmaceutical company Novartis has announced that it has chosen Holly Springs, North Carolina, as the location for its next vaccine plant. The investment is expected to create 350 jobs in the area. State officials awarded the company at least $6m in incentives to site the plant in North Carolina. Novartis intends to invest $267m in the plant, which will specialise in a new type of flu vaccine.


The company is a leader in pharmaceuticals and consumer health.

Icon opens Offices in Eastern Europe:

Icon Clinical, an Irish provider of outsourced development services to the pharmaceutical industry, has announced the opening of two new offices: in Warsaw and Vilnius. They complement the company’s existing network of offices in Riga, Moscow and Budapest.

Bachem sets up new US Unit:

Switzerland-based Bachem Group has announced the opening of a new production unit at its US subsidiary Bachem California in Torrance, California. The $10m unit will increase production capacity by 40%, responding to growing demand in North America.

Cordis plans facility in Ireland:

Florida-based Cordis, a Johnson & Johnson company, is to establish a development and manufacturing facility in Cashel, County Tipperary, with the support of development agency IDA Ireland.

The investment will create more than 450 new high-tech jobs over the next three years.

EDAP TMS to Launch German Subsidiary:

EDAP TMS, a French producer of high-intensity focused ultrasound equipment for the treatment of prostate cancer, has announced that it has launched a subsidiary in Flensburg, Germany. EDAP is addressing plans to expand faster and adapt its structure to meet growing market needs in Germany.